Quadrature Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-163,220
| Closed | -$10.8M | – | 1150 |
|
|
2024
Q3 | $10.8M | Buy |
+163,220
| New | +$10.8M | 0.24% | 86 |
|
|
2023
Q4 | – | Sell |
-71,305
| Closed | -$4.94M | – | 1205 |
|
|
2023
Q3 | $4.94M | Buy |
+71,305
| New | +$4.94M | 0.1% | 154 |
|
|
2023
Q1 | – | Sell |
-229,911
| Closed | -$17.2M | – | 998 |
|
|
2022
Q4 | $17.2M | Buy |
229,911
+188,262
| +452% | +$14M | 0.51% | 46 |
|
|
2022
Q3 | $3.45M | Buy |
41,649
+15,963
| +62% | +$1.32M | 0.11% | 174 |
|
|
2022
Q2 | $2.45M | Buy |
+25,686
| New | +$2.45M | 0.1% | 191 |
|
|
2020
Q3 | – | Sell |
-70,229
| Closed | -$4.85M | – | 785 |
|
|
2020
Q2 | $4.85M | Buy |
70,229
+35,654
| +103% | +$2.46M | 0.55% | 40 |
|
|
2020
Q1 | $2.18M | Sell |
34,575
-240,495
| -87% | -$15.1M | 0.52% | 46 |
|
|
2019
Q4 | $21.4M | Buy |
+275,070
| New | +$21.4M | 0.81% | 34 |
|
|
2019
Q3 | – | Sell |
-4,800
| Closed | -$296K | – | 587 |
|
|
2019
Q2 | $296K | Buy |
+4,800
| New | +$296K | 0.02% | 366 |
|
|
2018
Q3 | – | Sell |
-61,824
| Closed | -$3M | – | 633 |
|
|
2018
Q2 | $3M | Buy |
61,824
+56,415
| +1,043% | +$2.74M | 0.28% | 95 |
|
|
2018
Q1 | $252K | Buy |
+5,409
| New | +$252K | 0.02% | 511 |
|
|
2017
Q4 | – | Sell |
-238,956
| Closed | -$8.7M | – | 547 |
|
|
2017
Q3 | $8.7M | Buy |
+238,956
| New | +$8.7M | 1.09% | 15 |
|
|
2016
Q2 | – | Sell |
-114,069
| Closed | -$3.35M | – | 562 |
|
|
2016
Q1 | $3.35M | Buy |
+114,069
| New | +$3.35M | 0.47% | 58 |
|
|
2015
Q3 | – | Sell |
-27,738
| Closed | -$659K | – | 283 |
|
|
2015
Q2 | $659K | Buy |
+27,738
| New | +$659K | 0.6% | 58 |
|